Silence Therapeutics (SLN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

56.50p
   
  • Change Today:
    -1.40p
  • 52 Week High: 205.00
  • 52 Week Low: 54.41
  • Currency: UK Pounds
  • Shares Issued: 71.07m
  • Volume: 165,747
  • Market Cap: 40.15m
  • RiskGrade: 517
  • Beta: 0.26

SLN Overview

Silence Therapeutics is in the pharma and biotech sector and is currently trading at 56.50p per share. In the last year Silence Therapeutics's share price has ranged from 54.41p to 205.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (14-12-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -71950.0% -50.7%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2007.7 2.9
Pr/Book 0.8  
Latest F'cast
Revenue -97.4% 69900.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

SLN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 0.12 (9.00) (20.00)p n/a n/a n/a n/a 0.0%
31-Dec-14 0.01 (11.98) (22.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.43) (10.40)p n/a n/a n/a n/a 0.0%
31-Dec-16 0.77 (10.36) (12.10)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.02 (3.77) (2.30)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SLN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 14.00 (7.10) (0.10)p n/a n/a n/a n/a 0.0%
31-Dec-19 20.80 (4.30) (0.10)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Latest SLN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

SLN Market Data

Currency UK Pounds
Share Price 56.50p
Change Today -1.40p
% Change -2.42 %
52 Week High 205.00
52 Week Low 54.41
Volume 165,747
Shares Issued 71.07m
Market Cap 40.15m
Beta 0.26
RiskGrade 517

SLN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.49% above the market average53.49% above the market average53.49% above the market average53.49% above the market average53.49% above the market average
55.17% above the sector average55.17% above the sector average55.17% above the sector average55.17% above the sector average55.17% above the sector average
Price Trend
87.55% below the market average87.55% below the market average87.55% below the market average87.55% below the market average87.55% below the market average
70% below the sector average70% below the sector average70% below the sector average70% below the sector average70% below the sector average
Income Not Available
Growth
26.78% below the market average26.78% below the market average26.78% below the market average26.78% below the market average26.78% below the market average
38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average38.46% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 14-Dec-2018

Time Volume / Share Price
16:23 600 @ 57.10p
16:07 2,000 @ 55.20p
16:07 2,000 @ 55.20p
15:37 2,595 @ 57.80p
15:36 2,595 @ 57.80p

SLN Key Personnel

CEO David Horn Solomon

Top of Page